Ignite Creation Date:
2024-05-06 @ 8:37 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02779751
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-25
First Post:
2016-05-19
Brief Title:
A Study of Abemaciclib LY2835219 in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-19
First Submit QC Date:
May 19 2016
Study First Post Date:
2016-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-26
Last Update Post Date:
2024-03-25
Last Update Post Date Type:
ACTUAL